SCNI · Categories · Form 4
SCNI - SEC Form 4 insider transactions
Scinai Immunotherapeutics Ltd. (SCNI) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for SCNI
- Director Germain Mark was granted 120,000,000 units of Ordinary Shares (SEC Form 4)4 - Scinai Immunotherapeutics Ltd. (0001611747) (Issuer)
- Chief Executive Officer Reichman Amir was granted 400,000,000 units of Ordinary Shares, increasing direct ownership by 128% to 711,637,600 units (SEC Form 4)4 - Scinai Immunotherapeutics Ltd. (0001611747) (Issuer)